Policies and quality assurance in the pharmaceutical industry
- 1 December 1991
- journal article
- Published by Taylor & Francis in Accountability in Research
- Vol. 1 (4), 273-284
- https://doi.org/10.1080/08989629108573800
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Elements of a quality assurance program for pharmaceutical research & developmentAccountability in Research, 1990
- FDA Audits of Clinical Studies: Policy and ProcedureThe Journal of Clinical Pharmacology, 1990
- Controversy V: Phase I, First Time in Man StudiesThe Journal of Clinical Pharmacology, 1990
- New Drugs: First Time in ManThe Journal of Clinical Pharmacology, 1989
- Challenges in the Design of Phase I and Early Phase II StudiesDrug Information Journal, 1989
- Data audit: Its place in auditingAccountability in Research, 1989
- The role of data audits in detecting scientific misconduct. Results of the FDA programPublished by American Medical Association (AMA) ,1989
- Early clinical evaluation in man: the buck stops hereXenobiotica, 1987
- Planning for Program Effectiveness in Quality AssuranceEvaluation & the Health Professions, 1983
- On the nature and ethics of phase I clinical trials of cancer chemotherapiesPublished by American Medical Association (AMA) ,1982